SMTL ID : 3jsi.2 (1 other biounit)

Human phosphodiesterase 9 in complex with inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.72 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 6 residues within 4Å: Chain A: H.75, H.79, H.115, D.116, D.225 Ligands: MG.2 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:H.79, A:H.115, A:D.116, A:D.225

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 3 residues within 4Å: Chain A: D.116, E.145 Ligands: ZN.1 5 PLIP interactions: 1 interactions with chain A, 4 Ligand-Water interactions Metal complexes: A:D.116, H2O.1, H2O.1, H2O.1, H2O.1

1 x WTC: 6-benzyl-1-cyclopentyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one(Non-covalent)

WTC.3: 12 residues within 4Å: Chain A: F.74, H.75, M.188, I.226, V.240, L.243, L.244, Y.247, F.264, A.275, Q.276, F.279 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:V.240, A:L.243, A:L.243, A:L.244, A:Y.247, A:Y.247, A:A.275, A:F.279 Hydrogen bonds: A:Q.276, A:Q.276 pi-Stacking: A:F.279

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Verhoest, P.R. et al., Identification of a Brain Penetrant PDE9A Inhibitor Utilizing Prospective Design and Chemical Enablement as a Rapid Lead Optimization Strategy. J.Med.Chem. (2009)

Release Date

2009-12-01

Peptides

High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A

Related Entries With Identical Sequence